Microbial Enzyme Production: Critical Bottlenecks and Integrated Engineering Solutions

Abstract

Microbial enzymes are central to numerous industrial applications, yet their large-scale production remains constrained by persistent biological and process-level limitations. These include restricted secretion capacity, insufficient operational stability, scale-up inefficiencies, and downstream processing costs that can account for 45–65% of total manufacturing expenses. This review critically examines integrated genetic, physiological, and bioprocess engineering strategies developed to overcome these interconnected bottlenecks. Comparative analysis across major enzyme classes—cellulases, proteases, lipases, and amylases—reveals both universal constraints and enzyme-specific production challenges. Quantitative benchmarks indicate that multiplex genome engineering typically delivers 3–8-fold productivity improvements in optimized strains, while adaptive laboratory evolution enhances industrial robustness by 15–30%. Process intensification and continuous production approaches reduce processing times by 40–55%, albeit with increased capital requirements, and immobilization strategies enable 50–200 operational cycles with 65–85% retention of native activity. By synthesizing advances in strain engineering, secretion optimization, fermentation design, enzyme stabilization, and downstream integration within a techno-economic framework, this review highlights how coordinated interventions yield multiplicative gains over isolated strategies. Key future directions include systems-level characterization of secretion limits, AI-assisted enzyme stability engineering, and integrated manufacturing platforms. Collectively, these insights provide practical guidance for translating laboratory advances into economically viable microbial enzyme production systems.